Inability of murine peritoneal macrophages to convert linoleic acid into arachidonic acid. Evidence of chain elongation

R. S. Chapkin, S. D. Somers, Kent L Erickson

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Various murine macrophage populations synthesize and secrete large amounts of arachidonic acid (20:4n-6) derived eicosanoids (cyclo-oxygenase and lipoxygenase products). These metabolites are known to possess a wide variety of functions with regard to the initiation and regulation of inflammation and tumorigenesis. Because the dietary intake of 20:4n-6 is usually low, tissues are largely dependent upon dietary linoleic acid (18:2n-6) as an initial unsaturated precursor for the biosynthesis of 20:4n-6. The purpose of these experiments was to determine whether resident or responsive murine macrophages possess desaturase and elongase activities capable of in vitro conversion of 18:2n-6 into 20:4n-6. Peritoneal exudate macrophages were purified by adherence and incubated in serum-free medium containing fatty acid-free BSA with [1-14C]18:2n-6. Approximately 90 to 98% of the [14C]18:2n-6 at 4 and 16 h was recoverd in phosphatidylcholine and phosphatidylethanolamine. The metabolism of [14C]18:2n-6 was determined after transesterification and separation of the 14C-fatty acid methyl esters by argentation TLC, reverse phase HPLC, and electron impact gas chromatography/mass spectrometry. Resident and responsive macrophages lacked the capacity to transform [14C]18:2n-6 into 20:4n-6. In addition, prelabeled macrophages incubated with soluble, calcium ionophore A23187 or phorbol myristate, or particulate, zymosan, membrane perturbing agents also lacked Δ6 desaturase activity. All macrophages tested were capable of elongating [14C]18:2n-6 into [14C]20:2n-6. These observations suggest that 20:4n-6, present in macrophage phospholipids, is biosynthesized elsewhere and transported to the macrophage for esterification into the phospholipids. In addition, these findings demonstrate that elongase activity is present in both the resident and responsible peritoneal macrophage.

Original languageEnglish (US)
Pages (from-to)2350-2355
Number of pages6
JournalJournal of Immunology
Volume140
Issue number7
StatePublished - 1988

Fingerprint

Peritoneal Macrophages
Linoleic Acid
Arachidonic Acid
Macrophages
Phospholipids
Zymosan
Lipoxygenase
Eicosanoids
Calcium Ionophores
Esterification
Serum-Free Culture Media
Calcimycin
Myristic Acid
Exudates and Transudates
Prostaglandin-Endoperoxide Synthases
Phosphatidylcholines
Nonesterified Fatty Acids
Gas Chromatography-Mass Spectrometry
Carcinogenesis
Esters

ASJC Scopus subject areas

  • Immunology

Cite this

Inability of murine peritoneal macrophages to convert linoleic acid into arachidonic acid. Evidence of chain elongation. / Chapkin, R. S.; Somers, S. D.; Erickson, Kent L.

In: Journal of Immunology, Vol. 140, No. 7, 1988, p. 2350-2355.

Research output: Contribution to journalArticle

@article{60a010fc2f084a139290113bed917e6b,
title = "Inability of murine peritoneal macrophages to convert linoleic acid into arachidonic acid. Evidence of chain elongation",
abstract = "Various murine macrophage populations synthesize and secrete large amounts of arachidonic acid (20:4n-6) derived eicosanoids (cyclo-oxygenase and lipoxygenase products). These metabolites are known to possess a wide variety of functions with regard to the initiation and regulation of inflammation and tumorigenesis. Because the dietary intake of 20:4n-6 is usually low, tissues are largely dependent upon dietary linoleic acid (18:2n-6) as an initial unsaturated precursor for the biosynthesis of 20:4n-6. The purpose of these experiments was to determine whether resident or responsive murine macrophages possess desaturase and elongase activities capable of in vitro conversion of 18:2n-6 into 20:4n-6. Peritoneal exudate macrophages were purified by adherence and incubated in serum-free medium containing fatty acid-free BSA with [1-14C]18:2n-6. Approximately 90 to 98{\%} of the [14C]18:2n-6 at 4 and 16 h was recoverd in phosphatidylcholine and phosphatidylethanolamine. The metabolism of [14C]18:2n-6 was determined after transesterification and separation of the 14C-fatty acid methyl esters by argentation TLC, reverse phase HPLC, and electron impact gas chromatography/mass spectrometry. Resident and responsive macrophages lacked the capacity to transform [14C]18:2n-6 into 20:4n-6. In addition, prelabeled macrophages incubated with soluble, calcium ionophore A23187 or phorbol myristate, or particulate, zymosan, membrane perturbing agents also lacked Δ6 desaturase activity. All macrophages tested were capable of elongating [14C]18:2n-6 into [14C]20:2n-6. These observations suggest that 20:4n-6, present in macrophage phospholipids, is biosynthesized elsewhere and transported to the macrophage for esterification into the phospholipids. In addition, these findings demonstrate that elongase activity is present in both the resident and responsible peritoneal macrophage.",
author = "Chapkin, {R. S.} and Somers, {S. D.} and Erickson, {Kent L}",
year = "1988",
language = "English (US)",
volume = "140",
pages = "2350--2355",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "7",

}

TY - JOUR

T1 - Inability of murine peritoneal macrophages to convert linoleic acid into arachidonic acid. Evidence of chain elongation

AU - Chapkin, R. S.

AU - Somers, S. D.

AU - Erickson, Kent L

PY - 1988

Y1 - 1988

N2 - Various murine macrophage populations synthesize and secrete large amounts of arachidonic acid (20:4n-6) derived eicosanoids (cyclo-oxygenase and lipoxygenase products). These metabolites are known to possess a wide variety of functions with regard to the initiation and regulation of inflammation and tumorigenesis. Because the dietary intake of 20:4n-6 is usually low, tissues are largely dependent upon dietary linoleic acid (18:2n-6) as an initial unsaturated precursor for the biosynthesis of 20:4n-6. The purpose of these experiments was to determine whether resident or responsive murine macrophages possess desaturase and elongase activities capable of in vitro conversion of 18:2n-6 into 20:4n-6. Peritoneal exudate macrophages were purified by adherence and incubated in serum-free medium containing fatty acid-free BSA with [1-14C]18:2n-6. Approximately 90 to 98% of the [14C]18:2n-6 at 4 and 16 h was recoverd in phosphatidylcholine and phosphatidylethanolamine. The metabolism of [14C]18:2n-6 was determined after transesterification and separation of the 14C-fatty acid methyl esters by argentation TLC, reverse phase HPLC, and electron impact gas chromatography/mass spectrometry. Resident and responsive macrophages lacked the capacity to transform [14C]18:2n-6 into 20:4n-6. In addition, prelabeled macrophages incubated with soluble, calcium ionophore A23187 or phorbol myristate, or particulate, zymosan, membrane perturbing agents also lacked Δ6 desaturase activity. All macrophages tested were capable of elongating [14C]18:2n-6 into [14C]20:2n-6. These observations suggest that 20:4n-6, present in macrophage phospholipids, is biosynthesized elsewhere and transported to the macrophage for esterification into the phospholipids. In addition, these findings demonstrate that elongase activity is present in both the resident and responsible peritoneal macrophage.

AB - Various murine macrophage populations synthesize and secrete large amounts of arachidonic acid (20:4n-6) derived eicosanoids (cyclo-oxygenase and lipoxygenase products). These metabolites are known to possess a wide variety of functions with regard to the initiation and regulation of inflammation and tumorigenesis. Because the dietary intake of 20:4n-6 is usually low, tissues are largely dependent upon dietary linoleic acid (18:2n-6) as an initial unsaturated precursor for the biosynthesis of 20:4n-6. The purpose of these experiments was to determine whether resident or responsive murine macrophages possess desaturase and elongase activities capable of in vitro conversion of 18:2n-6 into 20:4n-6. Peritoneal exudate macrophages were purified by adherence and incubated in serum-free medium containing fatty acid-free BSA with [1-14C]18:2n-6. Approximately 90 to 98% of the [14C]18:2n-6 at 4 and 16 h was recoverd in phosphatidylcholine and phosphatidylethanolamine. The metabolism of [14C]18:2n-6 was determined after transesterification and separation of the 14C-fatty acid methyl esters by argentation TLC, reverse phase HPLC, and electron impact gas chromatography/mass spectrometry. Resident and responsive macrophages lacked the capacity to transform [14C]18:2n-6 into 20:4n-6. In addition, prelabeled macrophages incubated with soluble, calcium ionophore A23187 or phorbol myristate, or particulate, zymosan, membrane perturbing agents also lacked Δ6 desaturase activity. All macrophages tested were capable of elongating [14C]18:2n-6 into [14C]20:2n-6. These observations suggest that 20:4n-6, present in macrophage phospholipids, is biosynthesized elsewhere and transported to the macrophage for esterification into the phospholipids. In addition, these findings demonstrate that elongase activity is present in both the resident and responsible peritoneal macrophage.

UR - http://www.scopus.com/inward/record.url?scp=0023940247&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023940247&partnerID=8YFLogxK

M3 - Article

C2 - 3127464

AN - SCOPUS:0023940247

VL - 140

SP - 2350

EP - 2355

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 7

ER -